[ad_1] UBS named a raft of U.S. and global stocks it says are set to beat a major index in 2023, which it described as a year of “inflection points.” The stock picks are its “highest conviction” names, and the list is aimed at beating the MSCI All Countries World Index, the Swiss bank said … Read more
[ad_1] Jakub Porzycki | NurPhoto | Getty Images Global drugmaker Merck on Tuesday sued the Biden administration over Medicare‘s new powers to substantially reduce drug prices for seniors under the Inflation Reduction Act, the opening salvo in the pharmaceutical industry’s efforts to weaken the program. Merck called the law’s drug price negotiation program a “sham” … Read more
[ad_1] Traders work on the floor of the New York Stock Exchange on April 26, 2023 in New York City. Michael M. Santiago | Getty Images Stocks rose Thursday, as strong results from Meta Platforms boosted tech-related names, and investors weighed the latest data on the U.S. economy. The Dow Jones Industrial Average advanced 434 … Read more
[ad_1] The Merck logo at the Merck campus in Rahway, New Jersey. Brendan McDermid | Reuters Merck said on Sunday it will buy Prometheus Biosciences for about $10.8 billion, picking up a promising experimental treatment for ulcerative colitis and Crohn’s disease and building up its presence in immunology. Merck will pay $200 per share for … Read more
[ad_1] Pfizer‘s CEO signed on to an open letter calling for the reversal of a federal judge’s decision to suspend the Food and Drug Administration’s approval of the abortion pill mifepristone. Albert Bourla was among the more than 200 pharmaceutical company executives who signed the letter after U.S. Judge Matthew Kacsmaryk’s controversial ruling Friday. “We … Read more
[ad_1] Most of the time, the current crop of investors expects the market to go down. It has no illusions. Stocks are an inherently risky and the most dangerous of asset classes. Savers feel stuck with equities and those who espouse their positives often look like self-serving quacks. It wasn’t always like that. Back when … Read more